Schrier Robert W
University of Colorado School of Medicine, University of Colorado Denver School of Medicine, Department of Medicine Division of Renal Diseases and Hypertension 12077 East 19th Avenue, C281 Research Building 2, Room 7001 Aurora, CO 80045, United States.
Pharmacol Res. 2016 Dec;114:166-168. doi: 10.1016/j.phrs.2016.10.002. Epub 2016 Oct 26.
The review focuses on the common kidney disorder of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The potential pathogenetic role of the renin-angiotensin-aldosterone system (RAAS) in the renal cyst growth, the accompanying hypertension, and the frequency of increased left ventricular mass is considered. The therapeutic benefit of angiotensin converting enzyme inhibition (ACEI) in diminishing the renal cyst growth, treatment of the hypertension, and reversing the increased left ventricular mass in ADPKD is supportive of this possibility. The effects of ACEI related and unrelated to control of blood pressure are discussed.
该综述聚焦于常染色体显性多囊肾病(ADPKD)这一常见的肾脏疾病。肾素 - 血管紧张素 - 醛固酮系统(RAAS)在肾囊肿生长、伴随的高血压以及左心室质量增加频率方面的潜在致病作用得到了考量。血管紧张素转换酶抑制(ACEI)在减少ADPKD患者肾囊肿生长、治疗高血压以及逆转左心室质量增加方面的治疗益处支持了这种可能性。文中讨论了与血压控制相关和无关的ACEI的作用。